Search

everythinglearnresearchcommunity

for

Search:↓

Squaric acid dibutylester effectively treats alopecia areata.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.

Korean Red Ginseng saponins may protect skin from inflammation and darkening caused by air pollution.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

The research reveals how early embryonic mouse skin develops from simple to complex structures, identifying various cell types and their roles in this process.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

The AVET system effectively delivers genes to human keratinocytes and may help treat skin diseases.

FGF18 helps hair follicles resist radiation by stopping hair growth cycles.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Certain gene variations and irregular X chromosome activity may contribute to hair loss in women who can have children.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Malnutrition can cause unusual eyelash growth and hair loss.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Mutations in certain receptors can cause diseases and offer new treatment options.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.